A Study to Test Combination Treatments in Patients With Advanced Gastric Cancer
Status:
Active, not recruiting
Trial end date:
2023-12-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Nivolumab in combination with other
therapies is more effective than Nivolumab in combination with Ipilimumab in treating
patients/subjects with advanced gastric cancer.